Published in Am J Clin Nutr on June 01, 2000
Relation between Body Humors and Hypercholesterolemia: An Iranian Traditional Medicine Perspective Based on the Teaching of Avicenna. Iran Red Crescent Med J (2012) 4.30
Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J (2015) 1.92
Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology (2009) 1.27
Beta glucan: health benefits in obesity and metabolic syndrome. J Nutr Metab (2011) 1.24
Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: current understandings and future research priorities. Vasc Health Risk Manag (2008) 0.85
Symptoms associated with dietary fiber supplementation over time in individuals with fecal incontinence. Nurs Res (2011) 0.83
Serum lipid responses to psyllium fiber: differences between pre- and post-menopausal, hypercholesterolemic women. Nutr J (2008) 0.79
Recent publications by ochsner authors. Ochsner J (2001) 0.75
Effects of Dietary Supplementation with Agaricus sylvaticus Schaeffer on Glycemia and Cholesterol after Streptozotocin-Induced Diabetes in Rats. Evid Based Complement Alternat Med (2014) 0.75
Food Ingredients That Inhibit Cholesterol Absorption. Prev Nutr Food Sci (2017) 0.75
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med (1999) 5.09
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology (1995) 3.91
Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation (1999) 3.82
Serum cholesterol. Doing the right thing. Circulation (1993) 3.16
Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem (1969) 2.98
The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol (1993) 2.48
All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43
Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials. Am J Clin Nutr (2000) 2.21
Rationale of the diet-heart statement of the American Heart Association. Report of Nutrition Committee. Circulation (1982) 2.21
Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol (1995) 2.12
Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochem Biophys Res Commun (1972) 2.06
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest (1986) 1.96
Association between interleukin-8 concentration in nasal secretions and severity of symptoms of experimental rhinovirus colds. Clin Infect Dis (1998) 1.92
Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor. Mol Cell Biol (1984) 1.76
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest (1975) 1.69
Rationale of the diet-heart statement of the American Heart Association. Report of the Nutrition Committee. Circulation (1993) 1.58
Efficacy and safety of simvastatin 80 mg/day in hypercholesterolemic patients. The Expanded Dose Simvastatin U.S. Study Group. Am J Cardiol (1998) 1.56
LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler Thromb Vasc Biol (2000) 1.56
Maintenance of lower proportions of (n - 6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fatty acids. Biochim Biophys Acta (1992) 1.50
Effects of sleep deprivation on cognitive ability and skills of pediatrics residents. Acad Med (1989) 1.48
Long-term treatment of hypercholesterolemia with dietary fiber. Am J Med (1994) 1.47
Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. Science (1983) 1.44
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients. Ann Intern Med (1994) 1.44
Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women. Am J Cardiol (2000) 1.44
Continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol (2001) 1.43
Molecular cloning and sequence of a cDNA coding for bovine lipoprotein lipase. Proc Natl Acad Sci U S A (1987) 1.39
Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest (1982) 1.39
Purification and characterization of lipoprotein lipase from pig adipose tissue. J Biol Chem (1974) 1.39
Nucleotide sequence of PvuII polymorphic site at the human lipoprotein lipase gene locus. Nucleic Acids Res (1989) 1.38
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol (1995) 1.31
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA (1996) 1.29
Further separation of the apoproteins of the human plasma very low density lipoproteins. Biochim Biophys Acta (1970) 1.28
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol (2000) 1.27
Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation (1987) 1.25
Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins. Am J Physiol (1980) 1.24
Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets. Ann Intern Med (1993) 1.18
Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N Engl J Med (1985) 1.15
Glucose homeostasis in viral hepatitis. N Engl J Med (1970) 1.15
End products and fermentation balances for lactic streptococci grown aerobically on low concentrations of glucose. Appl Environ Microbiol (1977) 1.15
Identity of very low density lipoprotein apoproteins of plasma and liver Golgi apparatus. Science (1970) 1.14
Randomized, controlled trial of diabetic patient education: improved knowledge without improved metabolic status. Diabetes Care (1987) 1.14
Further characterization of apolipoproteins from the human plasma very low density lipoproteins. J Biol Chem (1970) 1.14
Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia. J Clin Invest (1972) 1.13
Further characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry (1970) 1.12
Accuracy of the Vitek system for antimicrobial susceptibility testing Enterobacteriaceae bloodstream infection isolates: use of "direct" inoculation from Bactec 9240 blood culture bottles. Diagn Microbiol Infect Dis (1997) 1.12
Order of polyadenylic acid addition and splicing events in early adenovirus mRNA formation. J Virol (1980) 1.09
Biological control of ticks. Parasitology (2004) 1.08
Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia. J Clin Invest (1979) 1.08
Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease. Clin Genet (1984) 1.07
Apolipoprotein E-enriched lipoprotein subclasses in normolipidemic subjects. J Lipid Res (1983) 1.07
Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog. J Clin Invest (1974) 1.07
Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins. J Lipid Res (1978) 1.07
Familial homozygous hypobetalipoproteinemia. Metabolism (1974) 1.07
Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes (1974) 1.07
Heart disease risk factors and hormone use in postmenopausal women. JAMA (1979) 1.06
Structure and polymorphic map of human lipoprotein lipase gene. Biochim Biophys Acta (1990) 1.06
Amelioration of hypertriglyceridaemia by progestational drugs in familial type-V hyperlipoproteinaemia. Lancet (1969) 1.05
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther (1999) 1.04
Effect of changing dietary fat saturation on low-density lipoprotein metabolism in man. Am J Physiol (1981) 1.04
A new method for the measurement of lipoprotein lipase in postheparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase. J Lipid Res (1979) 1.02
A comparison of molecular properties of hepatic triglyceride lipase and lipoprotein lipase from human post-heparin plasma. J Biol Chem (1978) 1.01
Changes in high-density lipoprotein protein composition after heparin-induced lipolysis. Am J Physiol (1971) 1.01
Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes. Diabetes Obes Metab (2010) 1.01
Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial. Mayo Clin Proc (2001) 0.99
Nephrogenic diabetes insipidus and lithium intoxication--complications of lithium carbonate therapy. N Engl J Med (1971) 0.99
Characterization of hypocholesterolemia in myeloproliferative disease. Relation to disease manifestations and activity. Am J Med (1981) 0.99
Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes (1982) 0.99
A method for separating the granulosa cells, the basal lamina and the theca of the preovulatory ovarian follicle of the domestic fowl (Gallus domesticus). J Reprod Fertil (1977) 0.99
Treatment of common lipoprotein disorders. Prog Cardiovasc Dis (1984) 0.98
Quantitative determination of hepatic and lipoprotein lipase activities from human postheparin plasma. J Lipid Res (1977) 0.97
Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism in man. J Lipid Res (1981) 0.97
Differential characteristics of purified hepatic triglyceride lipase and lipoprotein lipase from human postheparin plasma. J Lipid Res (1977) 0.97
Purification from human plasma of a heparin-released lipase with activity against triglyceride and phospholipids. J Biol Chem (1975) 0.97
Sources of cyclic nucleotides in plasma. J Clin Invest (1974) 0.97
Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia. Am J Med (2001) 0.96
Hypocholesterolemia and acute myelogenous leukemia. Association between disease activity and plasma low-density lipoprotein cholesterol concentrations. Cancer (1986) 0.96
Effect of a high carbohydrate diet on apoprotein-B catabolism in man. Metabolism (1981) 0.96
Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins. J Lipid Res (1985) 0.96
Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am J Clin Nutr (2001) 0.95
An efficient chromatographic system for lipoprotein fractionation using whole plasma. J Lipid Res (1998) 0.93
Incorporation of lean red meat into a National Cholesterol Education Program Step I diet: a long-term, randomized clinical trial in free-living persons with hypercholesterolemia. J Am Coll Nutr (2000) 0.92
A comparative study of post-heparin lipolytic activity and a purified human plasma triacylglycerol lipase. Biochim Biophys Acta (1974) 0.92
Combined lipase deficiency (cld/cld) in mice. Demonstration that an inactive form of lipoprotein lipase is synthesized. J Biol Chem (1985) 0.92
Lipoprotein metabolism in nonresponders to increased dietary cholesterol. Arteriosclerosis (1982) 0.91
Evaluation of insulin resistance in patients with primary hyperparathyroidism. Proc Soc Exp Biol Med (1975) 0.91
Effects of dietary supplementation with marine lipid concentrate on the plasma lipoprotein composition of hypercholesterolemic patients. Atherosclerosis (1989) 0.91
Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin. Metabolism (2000) 0.91
Serum thyroxine and triiodothyronine concentrations during iodide treatment of hyperthyroidism. J Clin Endocrinol Metab (1975) 0.90
Metabolism of apoprotein B in cynomolgus monkey: evidence for independent production of low-density lipoprotein apoprotein B. Am J Physiol (1983) 0.90
Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Metabolism (2000) 0.90
Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr (1999) 0.90
Synthesis de novo of purines in slices of rat brain and liver. J Neurochem (1970) 0.89
Effect of insulin therapy on insulin resistance in type II diabetic subjects. Evidence for heterogeneity. Diabetes (1981) 0.89
The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood. Pediatrics (1977) 0.89
Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study. Atherosclerosis (1990) 0.88